Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Schiffman KS, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift RA, Weaver CH, Demirer T, Sanders JE, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet JP, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner CD.
Schiffman KS, et al. Among authors: clift ra.
Bone Marrow Transplant. 1996 Jun;17(6):943-50.
Bone Marrow Transplant. 1996.
PMID: 8807098
Clinical Trial.